(1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum (ii) has been researched along with Local Neoplasm Recurrence in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batzl-Hartmann, C; Gust, R; Hartmann, RW; Maucher, A; Schertl, S; Schiller, CD; Schneider, MR; Schönenberger, H; Spruss, T; von Angerer, E | 1 |
1 other study(ies) available for (1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum (ii) and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Platinum(II) complexes interfering with testicular steroid biosynthesis: drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies.
Topics: Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Survival; Diethylstilbestrol; Dose-Response Relationship, Drug; Furans; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Organ Size; Organoplatinum Compounds; Prostatic Neoplasms; Pyrones; Rats; Rats, Sprague-Dawley; Testis; Testosterone | 2007 |